The thrombosis-related diseases are one of the leading causes of illness and death in the
general population, and despite significant improvements in long-term survival due to …

Preventing premature non-communicable disease mortality necessitates a thorough review
of one of the most important risk factors for stroke, which is atrial fibrillation (AF). The latter …

Optimizing the anticoagulation therapy is of pivotal importance in patients with a malignant
tumor, as venous thromboembolism (VTE) has become the second-leading cause of death …

Introduction: During the COVID-19 outbreak, non-urgent clinic visits or cardiac interventional
procedures were postponed to a later date, and the implementation of telemedicine has …

Currently, direct oral anticoagulants (DOACs) are the first-line anticoagulant strategy in
patients with non-valvular atrial fibrillation (NVAF). They are characterized by a more …

Measurement of direct oral anticoagulants (DOACs) activity is not routinely necessary.
Indeed, evaluation of DOACs plasmatic concentration is discouraged for the majority of …

Purpose Older age is associated with inappropriate dose prescription of direct oral
anticoagulants. The aim of our study was to describe the prevalence and the clinical …

Purpose Oral anticoagulants are crucial for preventing systemic thromboembolism in atrial
fibrillation (AF), with guidelines preferring non-vitamin K antagonist oral anticoagulants …

Background We investigated factors that influenced oral anticoagulant (OAC) initiation and
choice in Australian general practice patients newly diagnosed with AF. Methods Using an …

Background: Elderly patients are at high risk of both ischaemic and bleeding events, and the
low body weight is considered a risk factor for major bleeding in atrial fibrillation (AF) …